{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:19:45Z","timestamp":1791123585376,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jcf.2014.08.008","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T22:16:36Z","timestamp":1410819396000},"page":"219-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial"],"prefix":"10.1016","volume":"14","author":[{"given":"C.","family":"Conrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lymp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Chatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Quittell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Spahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Rubenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Herzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tirouvanziam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcf.2014.08.008_bb0005","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1152\/jappl.1993.75.6.2419","article-title":"Systemic deficiency of glutathione in cystic fibrosis","volume":"75","author":"Roum","year":"1993","journal-title":"J Appl Physiol"},{"issue":"2","key":"10.1016\/j.jcf.2014.08.008_bb0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/ajrccm.150.2.8049828","article-title":"Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation","volume":"150","author":"Konstan","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2014.08.008_bb0015","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"4 Pt 1","key":"10.1016\/j.jcf.2014.08.008_bb0020","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/ajrccm.156.4.96-11058","article-title":"Lower airway inflammation in infants and young children with cystic fibrosis","volume":"56","author":"Armstrong","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2014.08.008_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ppul.1950200203","article-title":"The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis","volume":"20","author":"Balough","year":"1995","journal-title":"Pediatr Pulmonol"},{"issue":"13","key":"10.1016\/j.jcf.2014.08.008_bb0030","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199503303321303","article-title":"Effect of high-dose ibuprofen in patients with cystic fibrosis","volume":"332","author":"Konstan","year":"1995","journal-title":"N Engl J Med"},{"issue":"8457","key":"10.1016\/j.jcf.2014.08.008_bb0035","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(85)92929-0","article-title":"Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis","volume":"2","author":"Auerbach","year":"1985","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jcf.2014.08.008_bb0040","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.200702-181OC","article-title":"Clinical use of ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis","volume":"176","author":"Konstan","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2014.08.008_bb0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0022-3476(95)70343-8","article-title":"A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group","volume":"126","author":"Eigen","year":"1995","journal-title":"J Pediatr"},{"issue":"9-10","key":"10.1016\/j.jcf.2014.08.008_bb0050","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0891-5849(99)00177-X","article-title":"Glutathione and its role in cellular functions","volume":"27","author":"Sies","year":"1999","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.jcf.2014.08.008_bb0055","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1073\/pnas.0511304103","article-title":"High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis","volume":"103","author":"Tirouvanziam","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jcf.2014.08.008_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1378\/chest.116.1.201","article-title":"Lymphocyte glutathione levels in children with cystic fibrosis","volume":"116","author":"Lands","year":"1999","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jcf.2014.08.008_bb0065","doi-asserted-by":"crossref","first-page":"L445","DOI":"10.1152\/ajplung.00419.2001","article-title":"Primary inflammation in human cystic fibrosis small airways","volume":"283","author":"Tirouvanziam","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"s29","key":"10.1016\/j.jcf.2014.08.008_bb0070","article-title":"Phase 2 trial of high-dose oral N-acetylcysteine as a systemic antioxidant and inhibitor of lung inflammation in CF","volume":"41","author":"Conrad","year":"2006","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"10.1016\/j.jcf.2014.08.008_bb0075","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.200609-1354OC","article-title":"Association between pulmonary function and sputum biomarkers in cystic fibrosis","volume":"75","author":"Mayer-Hamblett","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jcf.2014.08.008_bb0080","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1172\/JCI29444","article-title":"S-nitrosothiols signal hypoxia-mimetic vascular pathology","volume":"117","author":"Palmer","year":"2007","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.jcf.2014.08.008_bb0085","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcf.2009.04.003","article-title":"Patient-reported respiratory symptoms in cystic fibrosis","volume":"8","author":"Goss","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2014.08.008_bb0090","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1378\/chest.128.4.2347","article-title":"Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis","volume":"128","author":"Quittner","year":"2005","journal-title":"Chest"},{"issue":"Suppl. 1","key":"10.1016\/j.jcf.2014.08.008_bb0095","article-title":"Ataluren CF Study Group. Interim results of the phase 3 open-label study of ataluren in nonsense mutation cystic fibrosis (nmCF)","volume":"12","author":"Kerem","year":"2013","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.jcf.2014.08.008_bb0100","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2010.05.004","article-title":"Design and powering of cystic fibrosis clinical trials using rate of FEV(1) decline as an efficacy endpoint","volume":"9","author":"Konstan","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2014.08.008_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2014.08.008_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ppul.1950150204","article-title":"Pulmonary function between 6 and 18years of age","volume":"15","author":"Wang","year":"1993","journal-title":"Pediatr Pulmonol"},{"issue":"3","key":"10.1016\/j.jcf.2014.08.008_bb0115","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","volume":"152","author":"Standardization of Spirometry American Thoracic Society","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"24","key":"10.1016\/j.jcf.2014.08.008_bb0120","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199306173282403","article-title":"Efficacy of aerosolized tobramycin in patients with cystic fibrosis","volume":"328","author":"Ramsey","year":"1993","journal-title":"N Engl J Med"},{"issue":"8 Pt 1","key":"10.1016\/j.jcf.2014.08.008_bb0125","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1164\/ajrccm.164.8.2104075","article-title":"Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction","volume":"164","author":"Sagel","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2014.08.008_bb0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1067\/mpd.2002.129847","article-title":"Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis","volume":"141","author":"Sagel","year":"2002","journal-title":"J Pediatr"},{"issue":"8","key":"10.1016\/j.jcf.2014.08.008_bb0135","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/2047-783X-14-8-352","article-title":"A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis","volume":"14","author":"Dauletbaev","year":"2009","journal-title":"Eur J Med Res"},{"issue":"S30","key":"10.1016\/j.jcf.2014.08.008_bb0140","first-page":"228","article-title":"Assessment of induced sputum as a tool to evaluate anti-inflammatory agents in CF","volume":"42","author":"Chmiel","year":"2007","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.jcf.2014.08.008_bb0145","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.201303-0427OC","article-title":"Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial","volume":"188","author":"Griese","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2014.08.008_bb0150","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/toxsci\/kfq364","article-title":"The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis","volume":"120","author":"Zhang","year":"2011","journal-title":"Toxicol Sci"},{"issue":"3","key":"10.1016\/j.jcf.2014.08.008_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0898-6568(01)00233-9","article-title":"Redox regulation of TNF-alpha biosynthesis: augmentation by irreversible inhibition of gamma-glutamylcysteine synthetase and the involvement of an IkappaB-alpha\/NF-kappaB-independent pathway in alveolar epithelial cells","volume":"14","author":"Haddad","year":"2002","journal-title":"Cell Signal"},{"issue":"6","key":"10.1016\/j.jcf.2014.08.008_bb0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000340041","article-title":"N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats","volume":"84","author":"Li","year":"2012","journal-title":"Respiration"},{"issue":"3","key":"10.1016\/j.jcf.2014.08.008_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1042\/CBI20090007","article-title":"The effect of N-acetylcysteine on chloride efflux from airway epithelial cells","volume":"34","author":"Varelogianni","year":"2010","journal-title":"Cell Biol Int"},{"issue":"4","key":"10.1016\/j.jcf.2014.08.008_bb0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejcb.2008.11.003","article-title":"ER-associated complexes (ERACs) containing aggregated cystic fibrosis transmembrane conductance regulator (CFTR) are degraded by autophagy","volume":"88","author":"Fu","year":"2009","journal-title":"Eur J Cell Biol"},{"issue":"9","key":"10.1016\/j.jcf.2014.08.008_bb0175","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/ncb2090","article-title":"Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition","volume":"12","author":"Luciani","year":"2010","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10.1016\/j.jcf.2014.08.008_bb0180","doi-asserted-by":"crossref","first-page":"e3367","DOI":"10.1371\/journal.pone.0003367","article-title":"Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS One"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199314002082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199314002082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T11:57:06Z","timestamp":1598270226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199314002082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1569199314002082"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2014.08.008","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2014.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}